The current valuation score of BioMarin Pharmaceutical Inc is 8.01, ranking 110 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 39.20, which is 573.34% below the recent high of 263.97 and 60.97% above the recent low of 15.30.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.